The mc(2)-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects

Although the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine has been used since 1921, tuberculosis (TB) control still proceeds at a slow pace. The main reason is the variable efficacy of BCG protection against TB among adults, which ranges from 0-80%. Subsequently, the mc(2)-C...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Fábio Muniz, Trentini, Monalisa Martins, Junqueira-Kipnis, Ana Paula, Kipnis, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830111/
https://www.ncbi.nlm.nih.gov/pubmed/27074251
http://dx.doi.org/10.1590/0074-02760150411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830111/
https://www.ncbi.nlm.nih.gov/pubmed/27074251
http://dx.doi.org/10.1590/0074-02760150411

Ejemplares similares